BROADCASTS.com

In this edition of The Onco\u2019Zine Brief Peter Hofland talks with Dr. Muhammed Murtaza and Dr. Thomas Slavin about liquid biopsies

Murtaza is Assistant Professor and co-Director of the Center for Noninvasive Diagnostics at TGen in Phoenix, AZ, and Dr. Slavin is Assistant Clinical Professor, Departments of Medical Oncology & Therapeutics Research and Population Sciences, Division of Clinical Cancer Genomics at City of Hope Comprehensive Cancer Center in Duarte, California.

Hofland talks with Murtaza and Slavin specifically about a test called TARDIS \u2014 which stands for TARgeted DIgital Sequencing. This test, according to a study published earlier this year, is as much as 100 times more sensitive than other blood-based cancer monitoring tests. TARDIS is a \u201cliquid biopsy\u201d that specifically identifies and quantifies small fragments of cancer DNA circulating in the patient\u2019s bloodstream, known as circulating tumor DNA (ctDNA).
\xa0
About Onco'Zine
The Onco\u2019Zine Brief is developed in collaboration with the online journal, Onco\u2019Zine at www.oncozine.com - where you can find additional information and the latest news about cancer, cancer diagnosis and treatment, and cancer prevention.

How to support The Onco'Zine Brief
For more information about supporting The Onco\u2019Zine Brief, check our online journal Onco\u2019Zine at www.Onco\u2019Zine.com or visit Patreaon at https://www.patreon.com/theoncozinebrief

Newsletter
If you\u2019re living in the United States and want to receive our Newsletter, text the word CANCER to 66866 - and we\u2019ll make sure that you\u2019ll receive our newsletter which includes an overview of the latest news in oncology and hematology.

For more information about TARgeted DIgital Sequencing (TARDIS):
- Garcia D. Federal Grant helps TGen Refine Cancer-detection Blood Tests for Breast Cancer Patients. Onco'Zine - October 15, 2019 - https://www.oncozine.com/federal-grant-helps-tgen-refine-cancer-detection-blood-tests-for-breast-cancer-patients/
- Hofland P. New \u2018Liquid Biopsy\u2019 Helps to Improve Breast Cancer Diagnostics and Avoid Unnecessary Surgeries - August 8, 2019 - https://www.oncozine.com/new-liquid-biopsy-helps-improves-breast-cancer-diagnostics-and-avoid-unnecessary-surgeries/

Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.